NOT KNOWN FACTS ABOUT AROMASIN

AROMASIN is indicated for adjuvant treatment of postmenopausal Females with estrogen-receptor good early breast cancer which have acquired two to three years of tamoxifen and so are switched to AROMASIN for completion of a complete of 5 consecutive yrs of adjuvant hormonal therapy [see Clinical Scientific tests (fourteen.1)].Program assessment of 2